24 HR upadacitinib 30 MG Extended Release Oral Tablet [Rinvoq]

RxNorm concept 2590054, branded drug (sbd). Prescribable name: RINVOQ 30 MG 24HR Extended Release Oral Tablet.

RxCUI: 2590054
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2590054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

upadacitinib 2196092

Other names

Rinvoq 30 MG 24 HR Extended Release Oral Tablet

Related concepts

upadacitinib 30 MG (SCDC, consists of)
upadacitinib 30 MG [Rinvoq] (SBDC, consists of)
Extended Release Oral Tablet (DF, has dose form)
Rinvoq (BN, has ingredient)
24 HR upadacitinib 30 MG Extended Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2590054 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2590054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2590054. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.